Salt Lake City proclaims 'Molecular Imaging Days' during SNM's Annual Meeting in June

May 20, 2010

RESTON, Va.--Ralph Becker, mayor of Salt Lake City, Utah, has issued an official proclamation declaring June 5-9 "Molecular Imaging Days," coinciding with SNM's 57th Annual Meeting--one of the world's largest events focusing exclusively on fulfilling the educational and networking needs of the molecular imaging and therapy community.

"This is the first time that we have held our meeting in Salt Lake City," said Michael M. Graham, Ph.D., M.D., president of SNM. "Meeting attendees will have an opportunity to experience a beautiful city as they learn about advances in the field of molecular imaging to improve patient care."

SNM's Annual Meeting will bring together more than 6,000 members of the molecular imaging and nuclear medicine community, including physicians, technologists, scientists, physicists and pharmacists, to learn and share research about advances in the practice of molecular imaging and therapy.

Peter Herscovitch, M.D., chair of the scientific program committee, said, "There is no other event this large for nuclear medicine and molecular imaging scientists and practitioners. A top-notch educational and scientific program, exceptional networking opportunities and an attractive destination are just a few of the reasons why this year's meeting is a must-attend."

Annually, more than 20 million men, women and children undergo safe, noninvasive molecular imaging procedures with state-of-the-art imaging technologies--including PET and SPECT scans--to "photograph" biological targets or pathways in the body to help diagnose and treat disease and to evaluate how well treatment is working.

Molecular imaging is at the forefront of "personalized medicine" by providing patient-specific information that allows tailored treatment of disease. It is helping to advance the understanding, diagnosis, treatment and follow-up of cancer, cardiovascular disease and neurological disorders to improve the lives of people worldwide.

The mayor calls on all residents of the community to understand the benefits--historical, current and future--of molecular imaging and therapy.
-end-
About SNM--Advancing Molecular Imaging and Therapy

SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.

SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.

Society of Nuclear Medicine

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.
Can't connect to localhost. Errorcode: 1203